Table 3.
Subgroup analysis results of QSM values based on age and gender differences.
| Brain region | Subgroup | SMD (95%CI) | p-valuea | I2 (%)b/Phetrogenity | kc |
|---|---|---|---|---|---|
| Putamen | Age | ||||
| ≤ 69 | 0.68 (0.39, 0.96) | 0.06 | 0.00/0.31 | 4 | |
| > 69 | 1.73 (0.69, 2.77) | 89.69/0.00 | 4 | ||
| Sex (male%) | |||||
| ≤ 30% | 1.51 (0.61, 2.40) | 0.41 | 84.70/0.00 | 4 | |
| >30% | 0.98 (0.11, 1.85) | 89.66/0.00 | 4 | ||
| Geographic Distribution | |||||
| Asia | 1.33 (0.54, 2.12) | 0.53 | 90.56/0.00 | 6 | |
| Non Asia | 0.95 (0.08, 1.82) | 65.19/0.09 | 2 | ||
| Risk of bias (ROB) | |||||
| High ROB | 1.01 (0.15, 1.86) | 0.46 | 88.91/0.00 | 4 | |
| Low ROB | 1.48 (0.55, 2.42) | 86.35/0.00 | 4 | ||
| Globus pallidus | Age | ||||
| ≤ 69 | 0.26 (−0.04, 0.56) | 0.09 | 0.00/0.43 | 3 | |
| > 69 | 1.37 (0.14, 2.60) | 89.62//0.00 | 3 | ||
| Sex (male%) | |||||
| ≤ 30% | 0.65 (0.08, 1.22) | 0.72 | 64.21/0.07 | 3 | |
| >30% | 0.94 (−0.57, 2.46) | 94.70/0.00 | 3 | ||
| Risk of bias (ROB) | |||||
| High ROB | 0.80 (−0.29, 1.88) | 0.99 | 93.17//0.00 | 3 | |
| Low ROB | 0.81 (−0.14, 1.76) | 76.44/0.04 | 3 | ||
| Caudate nucleus | Age | ||||
| ≤ 69 | 0.53 (0.25, 0.81) | 0.02 | 0.00/0.52 | 4 | |
| > 69 | 1.20 (0.72, 1.69) | 14.32/0.28 | 2 | ||
| Sex (male%) | |||||
| ≤ 30% | 0.73 (0.38, 1.07) | 0.91 | 0.00/0.28 | 3 | |
| >30% | 0.77 (0.13, 1.41) | 73.24//0.03 | 3 | ||
| Geographic distribution | |||||
| Asia | 0.90 (0.54, 1.26) | 0.04 | 38.61/0.18 | 4 | |
| Non Asia | 0.30 (−0.16, 0.76) | 0.00/0.70 | 2 | ||
| Risk of bias (ROB) | |||||
| High ROB | 0.77 (0.34, 1.20) | 0.71 | 58.94/0.07 | 3 | |
| Low ROB | 0.60 (−0.16, 1.37) | 57.99//0.12 | 3 | ||
| Thalamus | Age | ||||
| ≤ 69 | −0.08 (−0.61, 0.44) | 0.12 | 47.27/0.17 | 2 | |
| > 69 | 1.57 (−0.48, 3.62) | 97.46//0.00 | 4 | ||
| Sex (male%) | |||||
| ≤ 30% | 2.53 (−2.01, 7.06) | 0.34 | 97.61/0.00 | 2 | |
| >30% | 0.31 (−0.18, 0.81) | 70.26//0.02 | 4 | ||
| Risk of bias (ROB) | |||||
| High ROB | 0.19 (−0.43, 0.81) | 0.26 | 73.03/0.02 | 2 | |
| Low ROB | 1.88 (−0.97, 4.72) | 98.00/0.00 | 4 | ||
AD, Alzheimer’s disease; CI, confidence interval; QSM, quantitative susceptibility mapping; SMD, standardized mean difference.
Test of group differences, p-value < 0.05.
A statistical measure of study heterogeneity.
Number of studies.